OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $26,129,000 | +16.3% | 5,278,672 | +83.9% | 0.66% | +6.8% |
| Q1 2015 | $22,476,000 | +16.6% | 2,870,492 | -9.7% | 0.62% | +37.8% |
| Q4 2014 | $19,269,000 | -6.5% | 3,179,762 | -34.3% | 0.45% | -5.1% |
| Q3 2014 | $20,611,000 | -27.6% | 4,838,324 | +5.1% | 0.47% | -16.7% |
| Q2 2014 | $28,459,000 | -14.6% | 4,604,958 | -10.2% | 0.57% | -5.8% |
| Q1 2014 | $33,339,000 | +17.3% | 5,129,129 | +1.6% | 0.60% | +5.8% |
| Q4 2013 | $28,415,000 | +29.4% | 5,047,119 | +40.8% | 0.57% | +7.9% |
| Q3 2013 | $21,966,000 | +3.1% | 3,583,342 | -1.7% | 0.53% | +19.4% |
| Q2 2013 | $21,312,000 | +49.3% | 3,646,260 | +59.9% | 0.44% | -6.1% |
| Q1 2013 | $14,273,000 | – | 2,280,053 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,229,287 | $9,625,000 | 44.28% |
| Foresite Capital Management II, LLC | 4,200,047 | $32,886,000 | 19.48% |
| Scale Management, LLC | 2,884,305 | $22,584,000 | 11.28% |
| Cheyne Capital Management (UK) LLP | 1,484,409 | $11,601,000 | 2.80% |
| Telemetry Investments, L.L.C. | 463,039 | $3,626,000 | 2.00% |
| NEA Management Company, LLC | 3,709,000 | $29,041,000 | 1.31% |
| Rock Springs Capital Management LP | 1,550,000 | $12,137,000 | 1.14% |
| Rhenman & Partners Asset Management AB | 831,800 | $6,513,000 | 1.10% |
| Tamarack Capital Management, LLC | 1,000,000 | $7,830,000 | 1.03% |
| RA Capital Management | 1,186,229 | $9,288,000 | 0.92% |